Member Info for CHELSEA7

06.35 Burble, thanks.

MMs began 3 v 3......now 4v 2

Taking 70k at 14.22

Well spotted rats, I would say that mirrors many hopes LTHs have

For 35k

Bid rising already started 14.07

I think that is a good RNS

Hi Burble, first one of the day perhaps 4.00a,m, would appreciate that

Ruck, haven"t been reading the BB much the last week or so, so would need to catch up with the significance before commenting on it, I was asking Burble earlier about how research has been affected by the recent glut of mutations, hopefully he will comment on that when he replies.

Morning Ruck, it serves as a very good reminder the transformation in our balance sheet during a very difficult time.

I seem to remember after each interim results RNS the focus was largely on the next raising and when, something we won"t be having today.

""Disappointing that SCIB2 is still in the CRUK vacuum ?""

Why?? We haven"t heard any news to the contrary, and surely getting back in SCIB1/Keytruda trial, MODI trial and COVIDITY are higher on Scancells priority list for now?

What I would like to know is the progress CRUK have made with SCIB2......or any during the time it has been with them.

Well done 2cvguy, well we knew the interims were due now and like this piece on MOD1...................

· Progress made towards initiation of Modi-1 Phase 1/2 clinical trial, with GMP drug manufacture advancing and formal regulatory-compliant toxicity studies complete

Cliff Holloway, Chief Executive Officer of Scancell, commented:



"We are pleased to report a period of strong operational and financial progress for Scancell, having transformed the Group's cash balance through two transactions with the support of our shareholders. 2021 is set to be an exciting year for the business. We continue to work towards developing an effective and differentiated vaccine against COVID-19, potentially active against new variants of the SARS-CoV-2 virus, whilst also making progress with our Moditope®, ImmunoBody® and AvidiMab™ platforms. We would like to thank our shareholders for their continued support over the past 6 months and look forward to utilising the proceeds raised to propel the business forward."

IMHO all companies have been affected by COVID 19 for initiating trials, how many companies during this difficult time have transformed their balance sheet as we have done, espeially on AIM??

"https://www.investegate.co.uk/scancell-hlds--sclp-/rns/interim-results-for-the-6-months-ended-31-oct-2020/202101290700032846N/

Burble,

A couple of weeks ago you replied to a question of mine regarding the vaccine companies immediately putting out statements that their vaccines would be as successful regardless of mutations known at the time. In the wake of more news about new mutations that seems to have stopped and is being replaced (IMHO) by companies still in trials and 2nd generation vaccines saying their vaccines are with the benefit of this are working well against the mutations, some even claiming early 60% success rates.

The EU Parliament have been scathing about the Astra Zeneca vaccine and the excuses behind "problems" with production capacity. My understanding is that Germany has decided not to give this vaccine to the over 65s where Europe seems pretty desperate for vaccine capacity.

I found your last reply valuable and would welcome your comments about how things stand now especially with different mutations being unearthed on a fairly regular basis.

I mentioned last time I would report back from my oncologist with regard to what measures Big Pharma are trying to adopt to get clinical trials restarted again. Well I did speak with him, but the conversation got lost with my faltering health again, and will be meeting him after a Pet Scan on the February 15th, maybe earlier, and will discuss his comments after that. ATB

Well that was some late finish on the share yesterday, as I said along with Miavoce, very hard to read too far the lines in trading the last week or more.

As I said very hard to distinguish buys from sells, but the 850k trades might just explain a rise that has been brewing for a few days.

Equally hard to use the word predictable, a mixed bag today and as we see that big buyer around. One thing I do know is that I better set my alarm early in the morning, something is brewing and it should be an interesting start. GL holders we could be seeing a move to a new trading range. In the 15s consensus was largely we are holding up well, well back to 14.50/15.50, time for our next move up.

I would say suspicion correct. ATB

Well done violindog.

In respect to your question I guess they are both smart, just a different end game perhaps??

So we close 14.50/15.50 +3.45%
I suggest it is hard to tell buys from sells, even hard reading Level 2. Take care all, goodnight.

20k

CFEP (MM) Have taken 215k shares, 100k, 65k, 50k at 14.50 & 14.58

Buyer about??

7k, showing as a sell

Lol c11 and a TICK UP on the Bid

14.50/15.5

Remember yesterday the bid went to 14.92 for a few.

14/15,50 +1.72%

Watch that Ask go!!!